Bill Snyder

Jordan Wright, MD, PhD, left, and Adel Eskaros, MBBS, PhD, are lead authors of the report on pancreatic exocrine-endocrine “crosstalk.” (photo by Susan Urmy)
November 1, 2023

Pancreas “crosstalk” may influence course of Type 1 and Type 2 diabetes

In the largest study of its kind, researchers at Vanderbilt have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity.

By Bill Snyder
November 1, 2023

A stroke left Kate Adamson trapped in her body, unable to communicate. Here’s how she recovered and became a VUMC social worker.

“You can see and hear everything around you, but you appear dead. It is like being locked in a glass coffin.”

By Bill Snyder
October 31, 2023

Polygenic “scores” may improve cancer screening

Accounting for genetic variability in biomarkers not associated with cancer risk could avoid unnecessary diagnostic procedures, Vanderbilt researchers found.

By Bill Snyder
October 31, 2023

VUMC’s Kimryn Rathmell wins Doris Duke Foundation Paragon Award

Kimryn Rathmell, MD, PhD, chair of Medicine at Vanderbilt University Medical Center, has received the Paragon Award for Research Excellence from the Doris Duke Foundation.

By Bill Snyder
October 30, 2023

Crowe, Osheroff honored by AAMC

Vanderbilt’s James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

By Bill Snyder
October 25, 2023

VUMC to help engage more study participants in research decisions

The All of Us Engagement Core at Vanderbilt University Medical Center is helping make human research more equitable, inclusive and stronger to accelerate the prevention and treatment of illness through genomic and precision medicine.

By Bill Snyder
October 19, 2023

VUMC initiative to address social drivers of health

Vanderbilt University Medical Center has received a federal grant to incorporate social drivers of health into adult primary care with the aim of improving outcomes for patients with multiple chronic conditions.
By Bill Snyder
October 17, 2023

AI predicts blood clot risk in hospitalized children: VUMC study

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.
By Bill Snyder
October 17, 2023

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.
By Bill Snyder
October 16, 2023

VUMC scientists record powerful signal in the brain’s white matter

Vanderbilt researchers report that when people who are having their brains scanned by fMRI perform a task, like wiggling their fingers, certain signals increase in white matter throughout the brain, which has long been thought to play a lesser role the more the brain's more energetic gray matter.
By Bill Snyder
October 13, 2023

How to overcome mistrust of medical science

A Vanderbilt expert in biomedical ethics says the public’s mistrust of medical science, including vaccination, is being driven in part by a top-down research enterprise that does not give human subjects a voice in the studies that affect them.
By Bill Snyder
October 12, 2023

Student researchers at VUMC earn accolades for their report

A research paper co-authored by 23 high school and undergraduate students participating in Vanderbilt University Medical Center’s Aspirnaut summer research program has been selected as one of the “Editor’s Picks” by the Journal of Biological Chemistry.
By Bill Snyder
1 … 4 5 6 7 8 … 110